Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. ACETABULAR CUP; HIP COMPONENT
FDA Home
Medical Devices
Databases
-
510(k)
|
DeNovo
|
Registration & Listing
|
Adverse Events
|
Recalls
|
PMA
|
HDE
|
Classification
|
Standards
CFR Title 21
|
Radiation-Emitting Products
|
X-Ray Assembler
|
Medsun Reports
|
CLIA
|
TPLC
MICROPORT ORTHOPEDICS INC. ACETABULAR CUP; HIP COMPONENT
Back to Search Results
Model Number
PHA06210
Medical Device Problem Code
Insufficient Device Problem Information (3190)
Health Effect - Clinical Code
Unspecified Infection (1930)
Date of Event
08/29/2013
Type of Reportable Event
Serious Injury
Event or Problem Description
Allegedly, wound infection in the patient right hip was detected.The patient had a medical intervention for wound debridement.
Search Alerts/Recalls
New Search
|
Submit an Adverse Event Report
Brand Name
ACETABULAR CUP
Common Device Name
HIP COMPONENT
Manufacturer
(Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key
10363176
Report Number
3010536692-2020-00552
Device Sequence Number
2228705
Product Code
HWT
UDI-Device Identifier
M684PHA062101
UDI-Public
M684PHA062101
Combination Product (Y/N)
N
Initial Reporter Country
DE
Number of Events Summarized
1
Summary Report (Y/N)
N
Device Implanted Year
2013
Reporter Type
Manufacturer
Report Source
company representative,study
Initial Reporter Occupation
Physician
Type of Report
Initial
Report Date
(Section B)
08/04/2020
1
Device was Involved in the Event
1
Patient was Involved in the Event
Is this an Adverse Event Report?
Yes
Is this a Product Problem Report?
No
Operator of Device
Health Professional
Device Model Number
PHA06210
Device Catalogue Number
PHA06210
Device Lot Number
1493566
Was Device Available for Evaluation?
No
Was the Report Sent to FDA?
No
Distributor Facility Aware Date
07/14/2020
Type of Report(Section G)
Thirty-Day
Initial Date Received by Manufacturer
07/14/2020
Initial Report FDA Received Date
08/04/2020
Patient Sequence Number
1
Outcome Attributed to Adverse Event
Required Intervention;
Patient Age
68 YR
Patient Weight
72
-
-